“Out of all the sectors I’ve invested in, in this last year, that’s my highest return,” said Kevin O’Leary in a recent interview about his investments in two psychedelics companies that have gone public this year. O’Leary was speaking with Jon Najarian of football and CNBC fame on the Compound Interest podcast. The first psychedelics company to go public was … [Read more...] about Kevin O’Leary: ‘Psychedelics Are My Highest Return This Year’
Analysis
Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.
MindMed CEO, JR Rahn, Pledges Stock For Loan (Not Sale)
There has been a lot of speculation circulating today after it appeared that the Founder and CEO of Mind Medicine (MMED), JR Rahn, sold half of his shares in the company. A sale by an insider, let alone a founder, of an early stage company is never a good sign as it implies that the founder is exiting the company for some unknown reason. This would be no different … [Read more...] about MindMed CEO, JR Rahn, Pledges Stock For Loan (Not Sale)
Update: Psychedelic Index Adds 12 New Companies
We're excited to announce that we've added 12 new companies to the Psychedelic Invest Index – making us fully up to date on all the recent listings. The Psychedelic Invest Index, the first ever to track the entire public sector of the psychedelic market, now features: Field Trip Health: FTRP:CSECompass Pathways: CMPS:NASDAQMindcure: MCUR:CSEGlobal Trac Solutions: … [Read more...] about Update: Psychedelic Index Adds 12 New Companies
The Right and Wrong Way To Invest in Psychedelics
The usage of psychedelic drugs as a therapeutic tool will have an enormous payoff for patients who are seeking new ways to cope with mental health issues. But the advancement of psychedelics is also going to have massive payoffs for early investors in companies that provide these therapies. We are already starting to see a handful of psychedelic therapy companies and … [Read more...] about The Right and Wrong Way To Invest in Psychedelics
New MindMed Warrants Offer An Interesting Buying Opportunity
Mind Medicine (MMED), one of the leading pharmaceutical companies exploring possible treatment options with psychedelic drugs, has announced a new stock offering. Mind Medicine (or, MindMed) announced that they have entered into an agreement with Canaccord Genuity Corp. for the purchase of 23,810,000 units of the company for C$1.05 per unit. The offering will raise … [Read more...] about New MindMed Warrants Offer An Interesting Buying Opportunity